Prostate-specific membrane antigen (PSMA) is a transmembrane glycoprotein that is highly overexpressed in prostate cancer cells, particularly in advanced and metastatic stages, while exhibiting limited expression in normal tissues (32, 33). The gene discussed is FOLH1; the disease is prostate carcinoma.